Guidewire Software Inc. Common Stock vs Eli Lilly And Co — how do they compare? Guidewire Software Inc. Common Stock trades at $163.81 (market cap $13.52B), while Eli Lilly And Co trades at $1,227.31 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 79.9× Guidewire Software Inc. Common Stock's market cap, and Eli Lilly And Co pays a 0.57% dividend while Guidewire Software Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Guidewire Software Inc. Common Stock for 0 Days and Eli Lilly And Co for 94 Days on average.
| GWRE | LLY | |
|---|---|---|
Market Cap | $13.52B | $1.08T |
Volume | 897,708 | 2,520,401 |
Sector | Technology | Health |
52-Week High | $254.23 | $1.28K |
52-Week Low | $102.69 | $799.57 |
Typical Hold Time | 0 Days | 94 Days |
Enterprise Value | $13.48B | $1.12T |
Dividend Yield | — | 0.57% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,166.51, down 1.36% on the day, amid strong fundamentals with revenue surging to $65.18B in 2025 and net income reaching $20.64B. The stock exhibits a bullish technical trend, supported by moving averages, with key resistance near $1,190. Recent news highlights promising pipeline developments in weight-loss drugs, reinforcing growth prospects.
Outlook remains positive given robust earnings beats, high analyst buy ratings (73%), and a consensus price target of $1,350. Risks include competitive pressures and execution challenges in scaling production. The stock's premium valuation (P/E 39.16) warrants monitoring, but strong cash flow and innovation pipeline support long-term upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Guidewire Software Inc. develops InsuranceSuite Cloud, a software platform used by property and casualty insurers for policy administration, billing, and claims processing.
Read more on GWRE →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →